The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...
RCGP chair Victoria Tzortziou Brown talks access; and Dr Keith Hopcroft discusses a report that suggests GPs are not following heart failure referral guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results